Autolus Therapeutics plc (AUTL)

Oncology Corporate Profile

Stock Performance

12.6600
-0.6400

HQ Location

Forest House, 58 Wood Lane
White City, London W12 7RZ

Company Description

Autolus is a clinical-stage, biopharmaceutical company, focused on the development and commercialisation of engineered T-cell immunotherapy products to combat cancer. Utilising its advanced cell programming and manufacturing technologies, Autolus has a pipeline of products in development for the treatment of both haematological malignancies and solid tumours. For further information please visit the Company’s website at: www.autolus.com

Website: https://www.autolus.com/

This company does not have any commercial products

This company does not have any pipeline products

Source: https://www.autolus.com/

Recent News Headlines

There are no news items to display